Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study

被引：0
作者：
Fernando A. Angarita
Amanda J. Cannell
Albiruni R. Abdul Razak
Brendan C. Dickson
Martin E. Blackstein
机构：
[1] University of Toronto,Division of General Surgery, Department of Surgery
[2] Mount Sinai Hospital,Department of Medical Oncology
[3] Princess Margaret Cancer Centre,Department of Medical Oncology
[4] University Health Network,Department of Medicine
[5] University of Toronto,Department of Pathology and Laboratory Medicine
[6] Mount Sinai Hospital,Department of Laboratory Medicine and Pathobiology
[7] University of Toronto,undefined
来源：
BMC Cancer | / 16卷
关键词：
Overall Survival; Soft Tissue Sarcoma; Partial Remission; Leiomyosarcoma; Liposarcoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[31]   The Use of Positron Emission Tomography in Soft Tissue Sarcoma Patients under Therapy with Trabectedin [J].
Kasper, Bernd ;
Schmitt, Thomas ;
Wuchter, Patrick ;
Dimitrakopoulou-Strauss, Antonia ;
Ho, Anthony D. ;
Egerer, Gerlinde .
MARINE DRUGS, 2009, 7 (03) :331-340
[32]   Safety and Efficacy of Percutaneous Cryoablation for Recurrent or Metastatic Soft-Tissue Sarcoma in Adult Patients [J].
Pal, Koustav ;
Awad, Ahmed ;
Yevich, Steven ;
Kuban, Joshua D. ;
Tam, Alda L. ;
Huang, Steven Y. ;
Odisio, Bruno C. ;
Gupta, Sanjay ;
Habibollahi, Peiman ;
Bishop, Andrew J. ;
Conley, Anthony P. ;
Somaiah, Neeta ;
Araujo, Dejka ;
Zarzour, Maria A. ;
Ravin, Ratan ;
Roland, Christina L. ;
Keung, Emily Z. ;
Sheth, Rahul A. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2024, 223 (04)
[33]   Adult soft tissue sarcoma [J].
Mann, GB ;
Lewis, JJ ;
Brennan, MF .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1999, 69 (05) :336-343
[34]   The Prognostic Impact of Unplanned Excisions in a Cohort of 728 Soft Tissue Sarcoma Patients: A Multicentre Study [J].
Maria Anna Smolle ;
Per-Ulf Tunn ;
Elisabeth Goldenitsch ;
Florian Posch ;
Joanna Szkandera ;
Marko Bergovec ;
Bernadette Liegl-Atzwanger ;
Andreas Leithner .
Annals of Surgical Oncology, 2017, 24 :1596-1605
[35]   PNI is useful for predicting the prognosis of patients with soft tissue sarcoma: A retrospective study [J].
Saito, Keiju ;
Kawabata, Yusuke ;
Kato, Ikuma ;
Shinoda, Satoru ;
Hayashida, Kenta ;
Fujita, Shintaro ;
Yoshida, Tomotaka ;
Choe, Hyonmin ;
Takeyama, Masanobu ;
Inaba, Yutaka .
JOURNAL OF ORTHOPAEDIC SCIENCE, 2025, 30 (03) :535-541
[36]   A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: The TRUSTS trial [J].
Bui-Nguyen, B. ;
Butrynski, J. E. ;
Penel, N. ;
Blay, J. Y. ;
Isambert, N. ;
Milhem, M. ;
Kerst, J. M. ;
Reyners, A. K. L. ;
Litiere, S. ;
Marreaud, S. ;
Collin, F. ;
van der Graaf, W. T. A. .
EUROPEAN JOURNAL OF CANCER, 2015, 51 (10) :1312-1320
[37]   Amputation for extremity soft tissue sarcoma does not increase overall survival: A retrospective cohort study [J].
Alamanda, V. K. ;
Crosby, S. N. ;
Archer, K. R. ;
Song, Y. ;
Schwartz, H. S. ;
Holt, G. E. .
EJSO, 2012, 38 (12) :1178-1183
[38]   Trabectedin for Advanced Soft Tissue Sarcoma: Ten Year Real-Life Perspective [J].
Shamai, Sivan ;
Merimsky, Ofer .
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2018, 20 (10) :599-603
[39]   The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS) [J].
Ploner, F. ;
Lamm, W. ;
Schur, S. ;
Eisterer, W. ;
Kuehr, T. ;
Lindorfer, A. ;
Tinchon, C. ;
Koestler, W. J. ;
Szkandera, J. ;
Brodowicz, T. .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) :1337-1342
[40]   Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker Analysis [J].
Imai, Toru ;
Kojima, Yuki ;
Shimoi, Tatsunori ;
Aiba, Hisaki ;
Okuma, Hitomi s. ;
Saito, Ayumi ;
Kita, Shosuke ;
Yamamoto, Kasumi ;
Maejima, Aiko ;
Nishikawa, Tadaaki ;
Sudo, Kazuki ;
Noguchi, Emi ;
Yoshida, Akihiko ;
Matsui, Yoshiyuki ;
Iwata, Shintaro ;
Kobayashi, Eisuke ;
Kawai, Akira ;
Udagawa, Ryoko ;
Fujiwara, Yasuhiro ;
Yonemori, Kan .
ANTICANCER RESEARCH, 2024, 44 (05) :2125-2132
12345